
Sanofi India Ltd is Rated Sell
2026-04-11 10:10:25Sanofi India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 11 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Sanofi India Ltd is Rated Sell
2026-03-31 10:10:13Sanofi India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Sanofi India Ltd Falls to 52-Week Low of Rs 3151 Amidst Prolonged Downtrend
2026-03-30 11:23:24A sustained decline has pushed Sanofi India Ltd to a fresh 52-week low of Rs 3,151.05 on 30 Mar 2026, marking a significant 53% drop from its peak of Rs 6,717.50 within the last year. This downturn comes despite pockets of strength in the company’s fundamentals, highlighting a complex interplay of market and company-specific factors.
Read full news article
Sanofi India Ltd Falls to 52-Week Low of Rs 3190.3 as Sell-Off Deepens
2026-03-27 15:28:29A sharp decline in Sanofi India Ltd has dragged the stock to a fresh 52-week low of Rs 3190.3 on 27 Mar 2026, marking a 45.64% drop over the past year and signalling sustained pressure amid broader market weakness.
Read full news article
Five Consecutive Losses Push Sanofi India Ltd to a New 52-Week Low
2026-03-24 10:55:47For the fifth straight session, Sanofi India Ltd closed lower, breaching its 52-week low at Rs 3,202.7 on 24 Mar 2026, marking a cumulative decline of 7.2% over this period.
Read full news article
Sanofi India Ltd Falls to 52-Week Low of Rs 3270 as Sell-Off Deepens
2026-03-23 10:49:47For the third consecutive session, Sanofi India Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 3,270 on 23 Mar 2026. This marks a significant 51.3% drop from its 52-week high of Rs 6,717.5, underscoring a sustained period of weakness amid broader market volatility.
Read full news article
Sanofi India Ltd Falls to 52-Week Low of Rs 3402 Amidst Prolonged Downtrend
2026-03-20 13:41:56A sustained decline has pushed Sanofi India Ltd to a fresh 52-week low of Rs 3402.05 on 20 Mar 2026, marking a significant 49.4% drop from its peak of Rs 6717.5 over the past year. This downturn contrasts sharply with the broader market, where the Sensex has gained 1.09% today and remains only 4.79% above its own 52-week low.
Read full news article
Sanofi India Ltd is Rated Sell
2026-03-20 10:10:18Sanofi India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Sanofi India Ltd Falls to 52-Week Low Amidst Continued Underperformance
2026-03-19 14:36:57Sanofi India Ltd’s share price has declined to a new 52-week low, closing just 0.06% above the lowest price of Rs 3,415.8. This marks a significant downturn for the pharmaceutical company, reflecting ongoing challenges in its financial performance and market positioning over the past year.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Apr-2026 | Source : BSEMUFG Intime India Private Limited (formerly known as Link Intime India Private Limited) Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the period ended 31st March 2026 under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018.
Announcement under Regulation 30 (LODR)-Newspaper Publication
03-Apr-2026 | Source : BSEPlease find enclosed copies of Newspaper publications.
Business Responsibility and Sustainability Reporting (BRSR)
02-Apr-2026 | Source : BSEPlease refer the attachment
Corporate Actions
No Upcoming Board Meetings
Sanofi India Ltd has declared 480% dividend, ex-date: 22 Apr 26
No Splits history available
No Bonus history available
No Rights history available






